Global Point-of-care Molecular Diagnostics Market Research Report

 The findings reviewed by GME stated that the Global Point-of-Care Molecular Diagnostics Market will expand with a CAGR value of 5.4 percent from 2021 to 2026. The growing demand for faster and more accurate diagnostic techniques is expected to be the major driver of the point-of-care molecular diagnostics market.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Point-of-care Molecular Diagnostics Market - Forecast to 2026" 

https://www.globalmarketestimates.com/market-report/global-point-of-care-molecular-diagnostics-market-3091

By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications), By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Test Location (Over-the-Counter, PoC), By End-User (Decentralized Labs, Hospitals, Homecare, Assisted Living Healthcare Facilities, Other Uses), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

 Key Market Insights

·         Point-of-care molecular diagnostics are diagnostic tests carried out to study and analyze the biological markers in the genome and proteome, cell expressions of genes as proteins through the use of molecular biology techniques.

·         The increasing investments in research & development of novel molecular diagnostic techniques are expected to increase the demand for point-of-care molecular diagnostics.

·         The decentralized laboratories segment analyzed to be the top segment in the market from 2021-2026.

·         Abbott Laboratories, Danaher Corporation, Johnson and Johnson, Cepheid, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bayer Healthcare, BioMerieux, among others, are the major vendors competing in the point-of-care molecular diagnosticsmarket.

 

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-point-of-care-molecular-diagnostics-market-3091

 

Application Outlook (Revenue, USD Billion, 2021-2026)

·         Infectious Diseases

·         Oncology

·         Hematology

·         Prenatal Testing

·         Endocrinology

·         Other Applications

Technology Outlook (Revenue, USD Billion, 2021-2026)

·         PCR-Based

·         Genetic Sequencing-Based

·         Hybridization-Based

·         Microarray-Based

Test Location Outlook (Revenue, USD Billion, 2021-2026)

·         Over-the-Counter

·         Point-of-Care

End-UserOutlook (Revenue, USD Billion, 2021-2026)

·         Decentralized Labs

·         Hospitals

·         Homecare

·         Assisted Living Healthcare Facilities

·         Other Uses

Regional Outlook (Revenue, USD Billion, 2021-2026)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

 

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php